What does Dr. Ruben Pauwels - Cardiologie do?

Dr. Ruben Pauwels - Cardiologie is a specialist medical practice in Gent. Private Limited, started on 8 September 2020, 1 establishment.

What is the address of Dr. Ruben Pauwels - Cardiologie?

The registered office of Dr. Ruben Pauwels - Cardiologie is located at Rijvisschepark 6, 9052 Gent.

Is Dr. Ruben Pauwels - Cardiologie still active?

Yes. According to the CBE (2 November 2026) Dr. Ruben Pauwels - Cardiologie is active, legal situation “Normale toestand”, started on 8 September 2020.

Is Dr. Ruben Pauwels - Cardiologie registered on Peppol?

Yes, Dr. Ruben Pauwels - Cardiologie is registered on the Peppol network with ID 0208:0753826095.

What is the enterprise number of Dr. Ruben Pauwels - Cardiologie?

The enterprise number of Dr. Ruben Pauwels - Cardiologie is BE0753826095.

When was Dr. Ruben Pauwels - Cardiologie founded?

Dr. Ruben Pauwels - Cardiologie was founded on 8 September 2020.

Who are the directors of Dr. Ruben Pauwels - Cardiologie?

According to the 2025 annual accounts, the directors of Dr. Ruben Pauwels - Cardiologie are: Ruben Pauwels.

Is Dr. Ruben Pauwels - Cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 September 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

How much profit did Dr. Ruben Pauwels - Cardiologie make in 2025?

Dr. Ruben Pauwels - Cardiologie posted a profit after taxes of € 267,382 in financial year 2025.

What is the revenue of Dr. Ruben Pauwels - Cardiologie?

As a small company, Dr. Ruben Pauwels - Cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 404,302.

Dr. Ruben Pauwels - Cardiologie (Private Limited) - Gent

Dossier Dr. Ruben Pauwels - Cardiologie, printed on 2 November 2026 from databakkes.be/en/0753826095/dr-ruben-pauwels-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Ruben Pauwels - Cardiologie from Gent, company number BE0753826095, closed financial year 2025 with a result of € 267,382 after tax. For that financial year Dr. Ruben Pauwels - Cardiologie recorded a gross margin of € 404,302 and equity of € 170,482. Compared with financial year 2024, the result moved from € 250,855 to € 267,382. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on June 24, 2026.

What it is worth Growing

€ 170,482

▲ 296% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 267,382

▲ 7% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 116,023

▲ 250% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 140,000 paid out

52 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 2,006

▼ 43% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 216,348

▼ 16% vs 2024

€ 42,090 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 408

▲ € 389 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 19,788

▲ 220% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 268,639 Gross margin 2022: € 268,639 First fiscal year in the series	€ 412,300 Gross margin 2023: € 412,300 ▲ 53% vs 2022 (€ 268,639) Favourable step	€ 363,320 Gross margin 2024: € 363,320 ▼ 12% vs 2023 (€ 412,300) Unfavourable step	€ 404,302 Gross margin 2025: € 404,302 ▲ 11% vs 2024 (€ 363,320) Favourable step	▲ 11%
Profit after taxes	€ 170,428 Profit after taxes 2022: € 170,428 First fiscal year in the series	€ 283,781 Profit after taxes 2023: € 283,781 ▲ 67% vs 2022 (€ 170,428) Favourable step	€ 250,855 Profit after taxes 2024: € 250,855 ▼ 12% vs 2023 (€ 283,781) Unfavourable step	€ 267,382 Profit after taxes 2025: € 267,382 ▲ 7% vs 2024 (€ 250,855) Favourable step	▲ 7%
Equity	€ 240,376 Equity 2022: € 240,376 First fiscal year in the series	€ 524,157 Equity 2023: € 524,157 ▲ 118% vs 2022 (€ 240,376) Favourable step	€ 43,100 Equity 2024: € 43,100 ▼ 92% vs 2023 (€ 524,157) Unfavourable step	€ 170,482 Equity 2025: € 170,482 ▲ 296% vs 2024 (€ 43,100) Favourable step	▲ 296%
Total debts	€ 388,401 Total debts 2022: € 388,401 First fiscal year in the series	€ 393,678 Total debts 2023: € 393,678 ▲ 1% vs 2022 (€ 388,401) Unfavourable step	€ 519,296 Total debts 2024: € 519,296 ▲ 32% vs 2023 (€ 393,678) Unfavourable step	€ 418,529 Total debts 2025: € 418,529 ▼ 19% vs 2024 (€ 519,296) Favourable step	▼ 19%
Cash	€ 267,114 Cash 2022: € 267,114 First fiscal year in the series	€ 24,495 Cash 2023: € 24,495 ▼ 91% vs 2022 (€ 267,114) Unfavourable step	€ 33,152 Cash 2024: € 33,152 ▲ 35% vs 2023 (€ 24,495) Favourable step	€ 116,023 Cash 2025: € 116,023 ▲ 250% vs 2024 (€ 33,152) Favourable step	▲ 250%
Retained profit	€ 239,376 Retained profit 2022: € 239,376 First fiscal year in the series	€ 523,157 Retained profit 2023: € 523,157 ▲ 119% vs 2022 (€ 239,376) Favourable step	€ 42,100 Retained profit 2024: € 42,100 ▼ 92% vs 2023 (€ 523,157) Unfavourable step	€ 169,482 Retained profit 2025: € 169,482 ▲ € 127,382 vs 2024 (€ 42,100) Favourable step	▲ € 127,382
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 731,912 Dividend 2024: € 731,912 Unchanged (€ 0) Unchanged	€ 140,000 Dividend 2025: € 140,000 ▼ 81% vs 2024 (€ 731,912) Unchanged	▼ 81%
Bank debt	€ 341,252 Bank debt 2022: € 341,252 First fiscal year in the series	€ 299,842 Bank debt 2023: € 299,842 ▼ 12% vs 2022 (€ 341,252) Favourable step	€ 258,211 Bank debt 2024: € 258,211 ▼ 14% vs 2023 (€ 299,842) Favourable step	€ 216,348 Bank debt 2025: € 216,348 ▼ 16% vs 2024 (€ 258,211) Favourable step	▼ 16%
Balance sheet total	€ 628,776 Balance sheet total 2022: € 628,776 First fiscal year in the series	€ 917,835 Balance sheet total 2023: € 917,835 ▲ 46% vs 2022 (€ 628,776) Unchanged	€ 562,396 Balance sheet total 2024: € 562,396 ▼ 39% vs 2023 (€ 917,835) Unchanged	€ 589,011 Balance sheet total 2025: € 589,011 ▲ 5% vs 2024 (€ 562,396) Unchanged	▲ 5%

Key figures of Dr. Ruben Pauwels - Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Ruben Pauwels - Cardiologie?

What happened at Dr. Ruben Pauwels - Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 24, 2026 New annual accounts for financial year 2025: profit of € 267,382 (▲ 7% vs 2024). Source: NBB ↗
Sep 10, 2020 Incorporation, published in the Gazette. Source: Staatsblad ↗
Sep 8, 2020 New establishment in Gent. KBO

In short

From € 170,428 profit in 2022 to € 267,382 profit in 2025.

Paid € 310,411 in corporate taxes since 2022.

Best year ever: 2023, with € 283,781 profit.

Paid out € 871,912 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Ruben Pauwels

Dr. Ruben Pauwels - Cardiologie

Behind Dr. Ruben Pauwels - Cardiologie is Ruben Pauwels.

Directors

According to the 2025 annual accounts

Ruben Pauwels

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rijvisschepark 6

9052 Gent

2.307.640.193

Groenebriel 1

9000 Gent

Active since 8 September 2020

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ADL ENDO

€ 415,597 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

10 September 2020 Source: Deed ↗

PAUWELS Ruben(oprichter) 100%

Details

Company number: 0753.826.095
VAT number: BE 0753.826.095
Registered office: Rijvisschepark 6, 9052 Gent
Names & denominations: Dr. Ruben Pauwels - Cardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 September 2020
Peppol: Active · Active since 10 Jan 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗